Linnaeus drug enters gold-standard healthy aging testing program (opens in new tab)

LNS8801 advances into the National Institute on Aging’s flagship lifespan-testing program, adding momentum to its healthy-aging ambitions. After securing a major ARPA-H award, Linnaeus Therapeutics will now face one of the toughest tests in longevity science: can it help organisms stay healthier and live longer? Aging research has entered its prove-it era. Researchers have identified […] The post appeared first on <a href="